Plant ID: NPO19166
Plant Latin Name: Helianthus niveus
Taxonomy Genus: Helianthus
Taxonomy Family: Asteraceae
NCBI TaxonomyDB:
73301
Plant-of-the-World-Online:
n.a.
China
TSHR; | |
UBE2N; | |
LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Enzyme_unclassified | UBE2N | Ubiquitin-conjugating enzyme E2 N | P61088 | CHEMBL6089 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0019825; oxygen binding | 2.352E-07 | 5.120E-03 | CYP19A1, CYP1A2, CYP2C19 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.205E-06 | 1.312E-02 | CYP1A2, CYP2C19 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 3.614E-06 | 1.968E-02 | CYP1A2, CYP2C19 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 5.300E-06 | 2.033E-02 | CYP1A2, CYP2C19 |
MF | GO:0005488; binding | GO:0020037; heme binding | 5.603E-06 | 2.033E-02 | CYP19A1, CYP1A2, CYP2C19 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 1.095E-05 | 2.650E-02 | CYP19A1, CYP1A2, CYP2C19 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 1.684E-05 | 3.667E-02 | CYP1A2, CYP2C19 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 2.028E-05 | 4.015E-02 | CYP19A1, CYP1A2 |
BP | GO:0008152; metabolic process | GO:0006706; steroid catabolic process | 2.605E-05 | 4.363E-02 | CYP19A1, CYP1A2 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 4.491E-05 | 6.520E-02 | CYP19A1, CYP2C19 |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 1.939E-03 | 7.965E-01 | CYP19A1, CYP1A2, CYP2C19 |
CC | GO:0016020; membrane | GO:0031090; organelle membrane | 3.989E-02 | 1.000E+00 | CYP1A2, CYP2C19, LMNA |
CC | GO:0043226; organelle | GO:0043231; intracellular membrane-bounded organelle | 4.289E-02 | 1.000E+00 | CYP19A1, CYP1A2, CYP2C19, LMNA, UBE2N |
CC | GO:0044464; cell part | GO:0005635; nuclear envelope | 4.958E-02 | 1.000E+00 | LMNA |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 3.034E-05 | 6.675E-04 | CYP1A2, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.744E-04 | 1.279E-03 | CYP1A2, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 1.231E-04 | 1.279E-03 | CYP1A2, CYP19A1 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 2.464E-04 | 1.355E-03 | CYP1A2, CYP2C19 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 4.116E-03 | 1.509E-02 | CYP1A2, CYP2C19, CYP19A1 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 1.194E-02 | 3.226E-02 | CYP1A2 |
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 1.491E-02 | 3.226E-02 | CYP19A1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04923 | Regulation of lipolysis in adipocytes | 1.668E-02 | 3.226E-02 | TSHR |
09160 Human Diseases | 09162 Immune diseases | hsa05320 | Autoimmune thyroid disease | 1.580E-02 | 3.226E-02 | TSHR |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 1.499E-03 | 6.597E-03 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|